Emyria

Subscribe to connect directly with our Management team  and be informed with our progress as we reimagine mental health care. 

About Emyria

D4, 661 Newcastle Street
Leederville WA 6007

Contact Us

Meet the Team

Announcements

New investors

Corporate Governance

Why Invest in Emyria?

Updates

Home

Pipeline

Montserrat

Emyria Limited

Emyria is building the future of mental health by combining advanced care models with proprietary drug development.

Pro-social compounds to enhance therapy outcomes

A novel treatment for Parkinson’s-related dyskinesia

These programs create valuable IP and expand our impact beyond the clinic.

At Emyria’s purpose-built clinics, we deliver safe, compassionate care to patients with complex mental health needs—while evaluating emerging treatment models.

Supported by specialist psychiatrists, experienced and compassionate therapists, we offer evidence-based care guided by rigorous ethics.

And, every patient journey generates real-world data that helps us improve care and accelerate the development of new therapies.

By gathering data with our patients we can refine patient selection, optimise care protocols, and enhance outcomes in symptom relief and quality of life.

transform outcomes for patients with the most complex mental health challenges

Our team combines frontline care with clinical research—

new therapies and breakthrough treatments

Every patient we support helps shape the future of mental health care..

 Putting patients first, applying bold science to complex care, and upholding high standards of honesty.

Championing diverse teams, and fostering respectful communication and feedback.

 Taking a disciplined, creative approach, while encouraging self-directed action.

Building strong partnerships to enhance our impact.

 Believing in a better tomorrow and creating value with every action.

To transform lives by improving outcomes for those facing the toughest mental health challenges.

We’re scaling world-class clinical services and advancing innovative treatments to set a new standard in mental healthcare.

Through strategic partnerships and cost-efficient innovation, we aim to make breakthrough therapies more accessible—while delivering strong, long-term value for our shareholders.

Emyria is poised to drive significant growth through our Empax Centre sites while introducing new advanced services to our suite of offerings. In parallel, We are engaging major health payers to broaden access and coverage for patients, while advancing our drug development programs in a cost-efficient manner via grant awards. With these strategic initiatives, Emyria is set to accelerate growth, enhance patient impact, and deliver substantial returns for our investors.

Australia has a number of unique regulatory advantages that allows Emyria to evaluate emerging treatments approaches years ahead of other markets, including the USA. 

 Developing and delivering innovative, world-first mental health treatments with a focus on patient impact and real-world data.

 Over 20 trained therapists and Australia's first Authorised Prescribers and growing!

 Fit-for-purpose centers equipped with the latest technology to enhance patient outcomes.

Partnerships with the University of Western Australia and the National Institutes of Health (NIH) in the USA.